Tallimustine in advanced previously untreated colorectal cancer, a phase II study.

por Punt, C. J., Humblet, Y., Roca, E., Dirix, L. Y., Wainstein, R., Polli, A., Corradino, I.
Publicado 1996

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab

por Siena, S, Peeters, M, Van Cutsem, E, Humblet, Y, Conte, P, Bajetta, E, Comandini, D, Bodoky, G, Van Hazel, G, Salek, T, Wolf, M, Devercelli, G, Woolley, M, Amado, R G
Publicado 2007

Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone

por Carrasco, J, Gizzi, M, Pairet, G, Lannoy, V, Lefesvre, P, Gigot, J-F, Hubert, C, Jouret-Mourin, A, Humblet, Y, Canon, J-L, Sempoux, C, Chapaux, X, Danse, E, Tinton, N, Navez, B, Van den Eynde, M
Publicado 2015